Abstract
The anterior segment of the eye ball, i. e., cornea and conjunctiva, serves as the barrier to the external stimuli. Cornea is transparent and is a “window” of the light sense, while conjunctiva covers the sclera, the main part of the eyeshell. Fibrosis/scarring in cornea potentially impairs vision by the reduction of its transparency and the alteration of the regular curvature. Fibrotic reaction in conjunctiva is also of clinical importance because inflammatory fibrosis in this tissue affects the physiology of the cornea and also a problem of post-eye surgery. In this review, we discuss the topic that is quite critical in vision. Although, various growth factors have been considered to be involved in, focus was put on the roles of transforming growth factor β (TGFβ).
Keywords: Fibrosis, Cornea, Conjunctiva, TGF, retina, glycosaminoglycans, GAGs, Myofibroblasts, subconjunctivalfibroblasts, Glaucoma, surgical fistula, mesenchymal cells, bleb tissue, mitogen-activated kinase, MAPK, CJun-N-terminal kinase, epithelium homeostasis, Smad7, interleukin-7, interferon-gamma andgene therapy, Connective tissue growth factor, CTGF, vernal conjunctivitis, ocular surfacescarring diseases, Stevens, –, Johnsons syndrome, TNF/JNK signal pathways
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title: Fibrosis in the Anterior Segments of the Eye
Volume: 10 Issue: 4
Author(s): Osamu Yamanaka, Chia-Yang Liu and Winston W.-Y. Kao
Affiliation:
Keywords: Fibrosis, Cornea, Conjunctiva, TGF, retina, glycosaminoglycans, GAGs, Myofibroblasts, subconjunctivalfibroblasts, Glaucoma, surgical fistula, mesenchymal cells, bleb tissue, mitogen-activated kinase, MAPK, CJun-N-terminal kinase, epithelium homeostasis, Smad7, interleukin-7, interferon-gamma andgene therapy, Connective tissue growth factor, CTGF, vernal conjunctivitis, ocular surfacescarring diseases, Stevens, –, Johnsons syndrome, TNF/JNK signal pathways
Abstract: The anterior segment of the eye ball, i. e., cornea and conjunctiva, serves as the barrier to the external stimuli. Cornea is transparent and is a “window” of the light sense, while conjunctiva covers the sclera, the main part of the eyeshell. Fibrosis/scarring in cornea potentially impairs vision by the reduction of its transparency and the alteration of the regular curvature. Fibrotic reaction in conjunctiva is also of clinical importance because inflammatory fibrosis in this tissue affects the physiology of the cornea and also a problem of post-eye surgery. In this review, we discuss the topic that is quite critical in vision. Although, various growth factors have been considered to be involved in, focus was put on the roles of transforming growth factor β (TGFβ).
Export Options
About this article
Cite this article as:
Yamanaka Osamu, Liu Chia-Yang and W.-Y. Kao Winston, Fibrosis in the Anterior Segments of the Eye, Endocrine, Metabolic & Immune Disorders - Drug Targets 2010; 10 (4) . https://dx.doi.org/10.2174/1871530311006040331
DOI https://dx.doi.org/10.2174/1871530311006040331 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy
Current Drug Targets miRNA: Small Molecules as Potential Novel Biomarkers in Cancer
Current Medicinal Chemistry Targeting Cytosolic Phospholipase A2α for Novel Anti-Inflammatory Agents
Current Medicinal Chemistry Recent Advances in Porphyrin-Derived Sensors
Current Organic Chemistry Animal Models of Diabetes Mellitus: Relevance to Vascular Complications
Current Pharmaceutical Design Therapeutic Applications of Liposomal Based Drug Delivery and Drug Targeting for Immune Linked Inflammatory Maladies: A Contemporary View Point
Current Drug Targets Mitochondria in Cancer Stem Cells: A Target for Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Isoenzyme Selective Phosphoinositide 3-Kinase Inhibition: What do the Stones Kill?
Current Signal Transduction Therapy Effects of Estrogen in the Brain: Is it a Neuroprotective Agent in Alzheimers Disease?
Current Aging Science Perinatal Exposure to Bisphenol A and Developmental Programming of the Cardiovascular Changes in the Offspring
Current Medicinal Chemistry Factors Driving the Choice of the Best Second-Line Treatment of Advanced NSCLC
Reviews on Recent Clinical Trials Environmental Risk Assessment of Replication Competent Viral Vectors Applied in Clinical Trials: Potential Effects of Inserted Sequences
Current Gene Therapy New Uses of Melatonin as a Drug; A Review
Current Medicinal Chemistry Current Understanding of the Interplay Between Catechol-OMethyltransferase Genetic Variants, Sleep, Brain Development and Cognitive Performance in Schizophrenia
CNS & Neurological Disorders - Drug Targets Viability of Nanotechnology in Ocular Therapeutics
Micro and Nanosystems Scorpion Extracts Inhibit Tumor Growth in Esophageal Cancer and Lung Adenocarcinoma
Current Signal Transduction Therapy Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets
CNS & Neurological Disorders - Drug Targets Orally Administrated Small Molecule Drugs with Intestine Targeted Profile: Recent Development and Prospects
Current Medicinal Chemistry Natural Products as Anti-glycation Agents: Possible Therapeutic Potential for Diabetic Complications
Current Diabetes Reviews Noninvasive Diagnosis of Chemotherapy Related Cardiotoxicity
Current Cardiology Reviews